MiNK Therapeutics (INKT) Misses Q2 EPS by 106c

MiNK Therapeutics (NASDAQ: INKT) reported Q2 EPS of ($1.06).

For earnings history and earnings-related data on MiNK Therapeutics (INKT) click here.

You May Also Be Interested In

• GSX Techedu Inc. (GOTU) Misses Q2 EPS by 11c; offers guidance
• Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
• Berenberg Upgrades Vestas Wind Systems A/S (VWS:DC) (VWDRY) to Buy